Capital Fund Management (CFM)’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-12,956
Closed -$1.1M 1647
2020
Q3
$1.1M Sell
12,956
-9,948
-43% -$503K 0.01% 848
2020
Q2
$812K Sell
22,904
-78,269
-77% -$2.29M 0.01% 756
2020
Q1
$1.36M Buy
101,173
+53,771
+113% +$905K 0.02% 659
2019
Q4
$1M Buy
+47,402
New +$836K 0.01% 1083
2018
Q4
Sell
-48,549
Closed -$1.01M 2336
2018
Q3
$1.01M Buy
+48,549
New +$1.15M 0.01% 1377

Capital Fund Management (CFM)'s IMMU Position: Q4 2020 in Review

Capital Fund Management (CFM) sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 12,956 shares — an estimated $1.1M sold.

Capital Fund Management (CFM) first reported a position in IMMU in Q3 2018 and held it in 5 quarters. The position peaked at $1.36M in Q1 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Capital Fund Management (CFM) reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 12,956 Immunomedics Inc shares in Q4 2020, an estimated $1.1M.
  • Capital Fund Management (CFM) first reported a position in Immunomedics Inc in Q3 2018 and held it in 5 quarters.
  • Capital Fund Management (CFM)'s Immunomedics Inc position peaked at $1.36M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2020, filed 12 Feb 2021.